THERAPEUTIC MECHANISM OF ELECTROACUPUNCTURE IN THE TREATMENT OF ULCERATIVE COLITIS IN THE RAT

被引:0
|
作者
黄裕新
田力
机构
[1] the Fourth Military Medical University
[2] Department of Gastroenterology
[3] China
[4] the Fourth Military Medical University Xi’an 710038
[5] Tangdu Hospital
[6] Shaanxi Province
关键词
Ulcerative colitis Electroacupuncture Serum interleukin-6 and Interleukin-8 Myeloperoxidase;
D O I
暂无
中图分类号
R245.97 [];
学科分类号
100512 ;
摘要
Aim: To investigate the regulatory effects of electroacupuncture (EA) at "Zusanli" (ST 36) on proinflammatory cytokines and myeloperoxidase (MPO) activity in rats with ulcerative colitis (UC), and further elucidate the underlying mechanism of EA on UC. Methods: Thirty-two male SD rats were randomly and evenly divided into four groups: normal control group; UC control group; "Zusanli" (ST 36, EA) group; non-acupoint group. A solution containing ethanol and 2,4,6-trinitrobenzenesulfonate was instilled into the distal colon in the rat (at a dose of 100 mg/kg) to set up UC model. Non-anesthetized rats of EA group were stimulated at ST-36 by electroacupuncture once a day, while those of non-acupoint group were done at the site 0.5 cm beside ST-36. After 10 days’ treatment, all rats were sacrificed simultaneously. Colon mucosal inflammation and damage were assessed by measuring colon mass, morphologic damage score, colonic MPO activity, contents of serum interleukin-6 (IL-6), interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-α). Morphologic damage score was examined under stereomicroscope. Colonic MPO was measured by spectrophotometric method. Serum TNF-α,IL-6 and IL-8 were determined by radioimmunoassay (RIA). Results: Both ratio of colonic mass/body mass (mC/mB) and activity of colonic MPO (μkat/g) in rats with UC were markedly increased (P<0.01 vs normal control group). Concentrations of serum TNF-α, IL-6 and IL-8 (ng/L) in rats of UC control group were significantly elevated (P<0.01 vs normal control group). In EA group, mC/mB and activity of MPO were decreased markedly compared with those of UC control group (P<0.05). Serum levels of TNF-α, IL-6 and IL-8 of ST-36 group were decreased by EA of ST-36 (P<0.01; P<0.05; P<0.05 vs UC control group). In comparison with UC control group, no significant changes were observed in the non-acupoint group. Furthermore, there were significant correlations among these parameters. Conclusion: In UC rats, serum TNF-α, IL-6 and IL-8 levels and MPO activity all increase significantly, indicating that these cytokines may cause inflammatory and immune response. EA stimulation induced downregulation on serum TNF-α, IL-6 and IL-8 levels and MPO activity may be responsible for its therapeutic effect in improving UC.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 50 条
  • [2] The Comparative Study of the Therapeutic Effects and Mechanism of Baicalin, Baicalein, and Their Combination on Ulcerative Colitis Rat
    Liang, Shuai
    Deng, Xin
    Lei, Lei
    Zheng, Yao
    Ai, Jiao
    Chen, Linlin
    Xiong, Hui
    Mei, Zhinan
    Cheng, Yung-Chi
    Ren, Yongshen
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [3] Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis
    Ramos, Laura
    Teo-Loy, Jeny
    Barreiro-de Acosta, Manuel
    FRONTIERS IN MEDICINE, 2023, 9
  • [4] Gut Microbiota: A New Strategy to Study the Mechanism of Electroacupuncture and Moxibustion in Treating Ulcerative Colitis
    Wei, Daneng
    Xie, Lushuang
    Zhuang, Zhiqi
    Zhao, Na
    Huang, Biao
    Tang, Yong
    Yu, Shuguang
    Zhou, Qizhi
    Wu, Qiaofeng
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019
  • [5] Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis
    Niels Vande Casteele
    Reena Khanna
    Pharmaceutical Research, 2017, 34 : 1556 - 1563
  • [6] Mirikizumab: A New Therapeutic Option for the Treatment of Ulcerative Colitis
    Choi, David
    Sheridan, Hilary
    Bhat, Shubha
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (11) : 1134 - 1139
  • [7] Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis
    Vande Casteele, Niels
    Khanna, Reena
    PHARMACEUTICAL RESEARCH, 2017, 34 (08) : 1556 - 1563
  • [8] THERAPEUTIC DIETS IN ULCERATIVE COLITIS
    TAYLOR, KB
    GASTROENTEROLOGY, 1966, 50 (02) : 300 - &
  • [9] THERAPEUTIC PROBLEMS IN ULCERATIVE COLITIS
    KIRSNER, JB
    PALMER, WL
    MEDICAL CLINICS OF NORTH AMERICA, 1953, (NCHIC) : 247 - 259
  • [10] Therapeutic efficacy and mechanism of Zhenrenyangzang decoction in rats with experimental ulcerative colitis
    Wang, Hui
    Li, Shu-Hua
    Zhang, Yan
    Guan, Jie
    Wu, Yan-Min
    Wang, Qi
    Luo, Xiao-Qing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 15254 - 15261